Miles Brittany, Panchbhavi Megna, Mackey James D
Medicine, University of Texas Medical Branch, Galveston, USA.
Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, USA.
Cureus. 2021 Oct 24;13(10):e19011. doi: 10.7759/cureus.19011. eCollection 2021 Oct.
Pregnancy and lactation-related osteoporosis (PLO) is the development of osteoporosis in a premenopausal woman, usually in the third trimester of pregnancy or puerperium. The hormonal changes that allow for the maternal-fetal calcium gradient may be the underlying cause for bone loss, but it is not currently known why some women are affected so severely. Because osteoporosis does not cause symptoms until the condition is advanced, diagnosis is usually made upon the development of an osteoporotic fracture or incidentally when imaging is performed for other reasons. Spontaneous recovery is common once lactation is discontinued, as the underlying hormonal factors that caused the osteoporosis revert to the pre-pregnancy state. We used the research database TriNetX (TriNetX, LLC, Cambridge, MA) to perform a query selecting women between the ages of 10 and 50 years old who experienced an osteoporotic fracture within 12 months of pregnancy. We analyzed the cohort of patients to determine the incidence of fractures at different skeletal locations and evaluated the medications that were utilized in the patients who received treatment.
妊娠和哺乳期相关骨质疏松症(PLO)是指绝经前女性发生的骨质疏松症,通常发生在妊娠晚期或产褥期。促成母胎钙梯度的激素变化可能是骨质流失的根本原因,但目前尚不清楚为什么有些女性受影响如此严重。由于骨质疏松症在病情进展之前不会引起症状,诊断通常是在发生骨质疏松性骨折时做出,或者在因其他原因进行影像学检查时偶然发现。一旦停止哺乳,自发恢复很常见,因为导致骨质疏松症的潜在激素因素会恢复到妊娠前状态。我们使用研究数据库TriNetX(TriNetX公司,马萨诸塞州剑桥)进行查询,选择年龄在10至50岁之间、在妊娠12个月内发生骨质疏松性骨折的女性。我们分析了该患者队列,以确定不同骨骼部位骨折的发生率,并评估接受治疗的患者所使用的药物。